Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF vs entecavir in chronic hepatitis B patients with low-level viraemia
ChiCTR2400089257Phase 4Completed
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir alafenamide in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoint: Complete virological response rate. Started Sep 2024; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2400089257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089257.